Deconstructing the intra-tumor subclonal heterogeneity of lung synchronous ground-glass nodules using whole-genome sequencing

doi:10.1038/s41392-022-00982-4

	Deconstructing the intra-tumor subclonal heterogeneity of lung synchronous ground-glass nodules using whole-genome sequencing
	Ren, Yijiu 1; Song, Minfang2 ; She, Yunlang 1; Xie, Huikang 1; Zheng, Hui 1; Chen, Chang 1; Zhang, Yiwen 3,4
	2022-05-27
发表期刊	SIGNAL TRANSDUCTION AND TARGETED THERAPY (IF:40.8[JCR-2023],40.5[5-Year])
ISSN	2095-9907
EISSN	2059-3635
卷号	7 期号:1
发表状态	已发表
DOI	10.1038/s41392-022-00982-4
URL	查看原文
收录类别	SCI ; SCIE
语种	英语
资助项目	National Natural Science Foundation of China[91959126] ; Shanghai Hospital Development Center[SHDC12017114] ; Shanghai Pulmonary Hospital Innovation Team[
WOS研究方向	Biochemistry & Molecular Biology ; Cell Biology
WOS类目	Biochemistry & Molecular Biology ; Cell Biology
WOS记录号	WOS:000805574800002
出版者	SPRINGERNATURE
文献类型	期刊论文
条目标识符	https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/195055
专题	生命科学与技术学院_博士生
共同第一作者	Song, Minfang; She, Yunlang
通讯作者	Chen, Chang; Zhang, Yiwen
作者单位	1.Tongji Univ, Shanghai Pulm Hosp, Dept Thorac Surg, Sch Med, Shanghai, Peoples R China 2.Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China 3.Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China 4.Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China
推荐引用方式 GB/T 7714	Ren, Yijiu,Song, Minfang,She, Yunlang,et al. Deconstructing the intra-tumor subclonal heterogeneity of lung synchronous ground-glass nodules using whole-genome sequencing[J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY,2022,7(1).
APA	Ren, Yijiu.,Song, Minfang.,She, Yunlang.,Xie, Huikang.,Zheng, Hui.,...&Zhang, Yiwen.(2022).Deconstructing the intra-tumor subclonal heterogeneity of lung synchronous ground-glass nodules using whole-genome sequencing.SIGNAL TRANSDUCTION AND TARGETED THERAPY,7(1).
MLA	Ren, Yijiu,et al."Deconstructing the intra-tumor subclonal heterogeneity of lung synchronous ground-glass nodules using whole-genome sequencing".SIGNAL TRANSDUCTION AND TARGETED THERAPY 7.1(2022).